Viewing nowIbisdil Tablet 150 mg (Irbesartan)
Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

MFDS item code 200703852 · Notified 2007.04.04 · Insurance code 650201450
Treatment of essential hypertension and diabetic nephropathy in patients with hypertension and type 2 diabetes
This medication is used to treat essential hypertension. Additionally, as part of hypertension therapy, it helps to slow the progression of kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it is effective in improving not only blood pressure control but also kidney health in diabetic patients.
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus, especially during pregnancy, therefore, it should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, the medication should be discontinued immediately. It should not be administered to patients with allergy reactions to this drug, severe liver impairment, specific renal diseases, or a history of angioedema. Elderly patients, those with elevated serum potassium levels, those with impaired liver function, and those with heart disease should use this medication with caution and require regular monitoring according to medical advice. Generally, side effects of this medication are mild and temporary, but dizziness, headaches, cough, indigestion, etc., may occur, and rarely serious side effects such as angioedema, hyperkalemia, liver dysfunction, and renal failure can occur, so caution is required. This medication can be taken with other antihypertensive medications; however, patients should be cautious as potassium supplements or potassium-sparing diuretics may lead to dangerously elevated potassium levels in the blood. When taken with lithium or non-steroidal anti-inflammatory drugs, the risk of renal function decline or side effects may increase, so patients should consult their physician. This medication is not recommended for breastfeeding women; it is advisable to discontinue breastfeeding when taking the medication. Safety has not been established for pediatric use, and dosage should start low and be administered with caution in elderly patients. In cases of overdose, hypotension and cardiac arrhythmias may occur; if overdose is suspected, immediate consultation with medical personnel and appropriate treatment is necessary. When storing, keep it out of reach of children, and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a sealed container. Additionally, it is important to store it in a cool and dry place below 30 degrees Celsius to maintain the medication's effectiveness.
White oval film-coated tablets
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

Irbesartan 150mg
Prescription medication
Dongwha Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.